← Retour à la une
Europe · Actualité générale · Daily Mirror

New Chinese jab could rival popular weight-loss drugs like Wegovy and Mounjaro

Publié par Daily Mirror · Royaume-Uni il y a 53 min
Ribupatide could help users shed a fifth of body weight in less than a year (stock)(Image: Getty Images)
Ribupatide could help users shed a fifth of body weight in less than a year (stock)(Image: Getty Images) · Daily Mirror

Résumé détaillé

Ribupatide is still being trialled in the UK, but some participants in a trial at Shanghai's Fudan University lost nearly a fifth of their body weight in 11 months

A new skinny jab could compete with popular weight-loss drugs like Wegovy, a study suggests.

Chinese-developed ribupatide is still being trialled in the UK, but early results show it can help some shed nearly a fifth of chub in less than 11 months. The findings come months after patients here were recruited for phase three trials of the drug.

During the study, folk on the highest dose of ribupatide lost 17.7 per cent of their body weight in just 11 months. Rival Wegovy, containing active ingredient semaglutide, generally helps shed 18.7 per cent in 16-and-a-half months. And Mounjaro, made with tirzepatide, sees users lose around 22.5 per cent over the same period. Like Mounjaro, Ribupatide works by mimicking two hormones that help control appetite and blood sugar.

To see more of the stories you love from The Mirror and to find them easily in Google then make us your preferred source. Free and easy-to-do, just click on the link here to find more from The Mirror at the top of your feed.

The study, conducted by researchers at Shanghai’s Fudan University, involved 567 overweight adults, with an average age of 34. Of these, 424 were randomly selected to have weekly ribupatide jabs at doses of 2mg, 4mg or 6mg, and the remaining 143 received a dummy placebo. After 48 weeks, patients given the lowest dose lost an average of 10.7 per cent of their starting weight.

Participants on the middle dose shed 16.4 per cent, while those taking the highest amount lost 17.7 per cent. Patients given the placebo injection lost just 1.4 per cent. Some shed even more, with 13.6 per cent of the 142 patients on 2mg losing at least a fifth of their body weight, rising to 37.1 per cent of the 141 taking 4mg and 44.4 per cent of the 141 taking 6mg.

The jab also appeared to offer benefits beyond weight loss, with researchers finding improvements in measurements like blood pressure, blood sugar control and cholesterol.

Triglycerides, a type of fat found in the blood that can cause serious health…

Weight…

Début de l'article, extrait de Daily Mirror. Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur Daily Mirror Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.mirror.co.uk)

À lire aussi